73 related articles for article (PubMed ID: 19145672)
21. Folinic acid, 5-fluorouracil and mitomycin C in metastatic breast cancer patients previously treated with at least two chemotherapy regimens.
Francini G; Petrioli R; Messinese S; Pozzessere D; Marsili S; Correale P; Sabatino M; Fiaschi AI
Cancer Chemother Pharmacol; 2002 Oct; 50(4):271-6. PubMed ID: 12357300
[TBL] [Abstract][Full Text] [Related]
22. Modified docetaxel-cisplatin in combination with capecitabine as first-line treatment in metastatic gastric cancer. a phase II study.
Polyzos A; Felekouras E; Karatzas T; Griniatsos J; Dimitroulis D; Polyzos K; Kontzoglou K; Mantas D; Karavokyros J; Nikiteas N; Tsavaris N; Syrigos K; Vafiadis I
Anticancer Res; 2012 Sep; 32(9):4151-6. PubMed ID: 22993377
[TBL] [Abstract][Full Text] [Related]
23. A tailored regimen including capecitabine and oxaliplatin for treating elderly patients with metastatic colorectal carcinoma Southern Italy Cooperative Oncology Group trial 0108.
Comella P; Gambardella A; Farris A; Maiorino L; Natale D; Massidda B; Casaretti R; Tafuto S; Lorusso V; Leo S;
Crit Rev Oncol Hematol; 2005 Feb; 53(2):133-9. PubMed ID: 15661564
[TBL] [Abstract][Full Text] [Related]
24. Capecitabine and bevacizumab in heavily pre-treated patients with advanced colorectal cancer.
Larsen FO; Boisen MK; Fromm AL; Jensen BV
Acta Oncol; 2012 Feb; 51(2):231-3. PubMed ID: 21936753
[TBL] [Abstract][Full Text] [Related]
25. Mitomycin C and lonidamine as second-line treatment of advanced colorectal cancer patients.
Maiello E; Giotta F; Gebbia V; Testa A; Galetta D; Riccardi F; Gebbia N; Colucci G
Anticancer Res; 1996; 16(5B):3177-9. PubMed ID: 8967732
[TBL] [Abstract][Full Text] [Related]
26. Capecitabine plus cisplatin as first-line chemotherapy for advanced biliary tract cancer: a retrospective single-center study.
Woo SM; Lee WJ; Han SS; Park SJ; Kim TH; Koh YH; Kim HB; Hong EK; Park JW; Kim CM
Chemotherapy; 2012; 58(3):225-32. PubMed ID: 22831988
[TBL] [Abstract][Full Text] [Related]
27. Phase II study of capecitabine and mitomycin C as first-line treatment in patients with advanced colorectal cancer.
Rao S; Cunningham D; Price T; Hill ME; Ross PJ; Tebbutt N; Norman AR; Oates J; Shellito P
Br J Cancer; 2004 Aug; 91(5):839-43. PubMed ID: 15266319
[TBL] [Abstract][Full Text] [Related]
28. Mitomycin C and capecitabine combination (MiXe) in heavily pretreated metastatic breast cancer patients. A dose-finding study.
Maisano R; Caristi N; Mare M; Mafodda A; Carboni R; Montalto E; Iorfida M; Nardi M
Anticancer Res; 2005; 25(6C):4513-7. PubMed ID: 16334135
[TBL] [Abstract][Full Text] [Related]
29. Combination of capecitabine and mitomycin C as first-line treatment in patients with metastatic breast cancer.
Vrdoljak E; Boban M; Omrcen T; Hrepic D; Fridl-Vidas V; Boskovic L
Neoplasma; 2011; 58(2):172-8. PubMed ID: 21275468
[TBL] [Abstract][Full Text] [Related]
30. Capecitabine and mitomycin C as third-line therapy for patients with metastatic colorectal cancer resistant to fluorouracil and irinotecan.
Chong G; Dickson JL; Cunningham D; Norman AR; Rao S; Hill ME; Price TJ; Oates J; Tebbutt N
Br J Cancer; 2005 Sep; 93(5):510-4. PubMed ID: 16091760
[TBL] [Abstract][Full Text] [Related]
31. Salvage chemotherapy in metastatic colorectal cancer with the combination of capecitabine and mitomycin C.
Zygulska AL; Krzemieniecki K
Neoplasma; 2015; 62(5):793-7. PubMed ID: 26278141
[TBL] [Abstract][Full Text] [Related]
32. Mitomycin C and capecitabine in pretreated patients with metastatic gastric cancer: a multicenter phase II study.
Miranda MB; Hartmann JT; Al-Batran SE; Kripp M; Gencer D; Hochhaus A; Hofheinz RD; Merx K
J Cancer Res Clin Oncol; 2014 May; 140(5):829-37. PubMed ID: 24556803
[TBL] [Abstract][Full Text] [Related]
33. Chemotherapy with mitomycin C and capecitabine in patients with advanced colorectal cancer pretreated with irinotecan and oxaliplatin.
Rimassa L; Gullo G; Carnaghi C; Abbadessa G; Zuradelli M; Tronconi MC; Pressiani T; Santoro A
Tumori; 2006; 92(4):285-9. PubMed ID: 17036517
[TBL] [Abstract][Full Text] [Related]
34. Capecitabine and mitomycin C may be an effective treatment option for third-line chemotherapy in advanced colorectal cancer.
Scartozzi M; Falcone A; Pucci F; Braconi C; Pierantoni C; Cavanna L; Franciosi V; Berardi R; Beretta G; Masi G; Allegrini G; Zaniboni A; Labianca R; Cascinu S
Tumori; 2006; 92(5):384-8. PubMed ID: 17168429
[TBL] [Abstract][Full Text] [Related]
35. Phase II trial of erlotinib and capecitabine for patients with previously untreated metastatic colorectal cancer.
Kozuch P; Malamud S; Wasserman C; Homel P; Mirzoyev T; Grossbard M
Clin Colorectal Cancer; 2009 Jan; 8(1):38-42. PubMed ID: 19203895
[TBL] [Abstract][Full Text] [Related]
36. Capecitabine-related increased mean corpuscular volume of red blood cell may be a predictive marker of treatment response and survival in patients with metastatic colorectal cancer.
Cokmert S; Demir L; Can A; Akyol M; Vedat Bayoglu I; Dirican A; Kucukzeybek Y; Erten C; Oktay Tarhan M
J BUON; 2014; 19(1):75-82. PubMed ID: 24659646
[TBL] [Abstract][Full Text] [Related]
37. Capecitabine and temozolomide (CAPTEM) for metastatic, well-differentiated neuroendocrine cancers: The Pancreas Center at Columbia University experience.
Fine RL; Gulati AP; Krantz BA; Moss RA; Schreibman S; Tsushima DA; Mowatt KB; Dinnen RD; Mao Y; Stevens PD; Schrope B; Allendorf J; Lee JA; Sherman WH; Chabot JA
Cancer Chemother Pharmacol; 2013 Mar; 71(3):663-70. PubMed ID: 23370660
[TBL] [Abstract][Full Text] [Related]
38. Treatment of a patient with advanced esophageal cancer with a combination of mitomycin C and capecitabine: activation of the thymidine phosphorylase as active principle?
Hofheinz RD; Weisser A; Willer A; Hehlmann R; Hochhaus A
Onkologie; 2003 Apr; 26(2):161-4. PubMed ID: 12771525
[TBL] [Abstract][Full Text] [Related]
39. DC vaccine therapy combined concurrently with oral capecitabine in metastatic colorectal cancer patients.
Liu Y; Zhang W; Zhang B; Yin X; Pang Y
Hepatogastroenterology; 2013; 60(121):23-7. PubMed ID: 22945335
[TBL] [Abstract][Full Text] [Related]
40. Capecitabine and mitomycin C in patients with metastatic colorectal cancer resistant to fluorouracil and irinotecan.
Alliot C
Br J Cancer; 2006 Mar; 94(6):935-6; author reply 937. PubMed ID: 16495915
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
